Drug delivery via conformal film

• US 20020115985A1
• Filed: 10/29/2001
• Published: 08/22/2002
• Est. Priority Date: 01/27/1999
• Status: Abandoned Application

• Current Assignee: Eugene A. Larson, Marian L. Larson
• Original Assignee: Eugene A. Larson, Marian L. Larson
• Inventors: Larson, Marian L., Larson, Eugene A.
• Application Number:
  US10/045,688
• Publication Number:
  US 20020115985A1
• Time in Patent Office: Days
• US Class Current: 604/890.1
• CPC Class Codes: A61K 9/0024 Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue compositions for intravenous administration, normal injectable solutions or dispersions for, e.g. subcutaneous administration A61K9/0019; brain implants A61K9/0085; (coated) prostheses, catheters or stents A61L
• CPC Class Codes: A61K 9/7015 Drug-containing film-forming compositions, e.g. spray-on
• CPC Class Codes: A61L 2300/606 Coatings
• CPC Class Codes: A61L 31/16 Biologically active materials, e.g. therapeutic substances A61L31/047 takes precedence

Abstract

A drug delivery conformal film system according to the present invention is adapted to be compounded and applied, by medical personnel at the point of use, to a medical device such as a cardiovascular and urology stent, pacemaker, vascular graft, suture ring of mechanical heart valve, implantable infusion port, implantable drug delivery pump, orthopedic hardware and appliance, and, neurological stimulating device. The drug delivery conformal film consists of one of three in vivo biocompatible; biodegradable, bio-erodable or bioabsorbable embodiments: (1) cross-linked sodium alginate, (2) UV photo-active polymer, or, (3) hydrogels. An implantable medical device such as the stent or suture ring of a mechanical artificial heart valve is coated with an in vivo biocompatible; biodegradable or bioerodable or bioabsorbable solution comprising a polymer and containing a drug, the solution is cross-linked or cured to form a film on the device immediately prior to placement in the body. When the coated device is introduced into the body, the drug contained in the coating is released in a local region. The invention provides a point of use in vivo drug delivery system whereby the drug and its concentration can be selected by medical personnel immediately prior to implantation of the medical device.

Claims

1. An implantable drug-delivering medical device for implantation into a recipient, said device comprising:

an implantable medical device,

a film adhered to said device, said film comprising an in vivo biocompatible and biodegradable or bioabsorbable or bioerodable polymer, said film further comprising a desired dosage amount of one or more predetermined drugs,

wherein the desired dosage amount of said one or more predetermined drugs is selected based on particular dosage requirements of said recipient and wherein said film is adhered to said medical device immediately prior to implantation of said medical device into said recipient.

2. The device of claim 1 wherein said polymer comprises alginates.

3. The device of claim 2 wherein said alginates comprise sodium alginate.

4. The device of claim 3 wherein said sodium alginate is present in the range of about 1 wt. % to about 8 wt. % and has a molecular weight in the range of 12,000 to 190,000.

5. The device of claim 1 wherein said polymer comprises hydrogels.

6. The device of claim 1 wherein said implantable medical device comprises a stent.

7. The device of claim 1 wherein said implantable medical device comprises at least one of pacemaker, vascular graft, suture ring, implantable infusion port, implantable drug delivery pump, orthopedic hardware and appliances, and, neurological stimulating device.

8. The device of claim 1 wherein said film is sterile.

9. The device of claim 1 wherein said film is formed in the presence of a cross-linking agent.

10. The device of claim 9 wherein said cross-linking agent comprises at least one of calcium chloride, CaSO₄, MgCl, MgSO₄, and barium compounds.

11. The device of claim 10 wherein said cross-linking agent comprises calcium chloride.

12. The device of claim 1 wherein said film exhibits elasticity in an amount greater than 200%.

13. The device of claim 1 wherein said film is adhered to said device in a uniform thickness or in a non-uniform thickness.

14. The device of claim 1 wherein said polymer comprises polyethylene glycol or derivatives and copolymers of polyethylene glycol.

15. The device of claim 5 wherein said hydrogels comprises a mixture of polyethylene oxide and polyethylene glycol.

16. The device of claim 1 wherein said one or more predetermined drugs are at least one of water soluble drugs and non-water soluble drugs.

18. The device of claim 17 wherein said implantable medical device comprises a stent.

20. The device of claim 19 wherein said film is lubricious.

17. An implantable drug-delivering medical device for implantation into a recipient, said device comprising:

an implantable medical device,

a film adhered to said device, said film comprising sodium alginate, said film further comprising a desired dosage amount of one or more predetermined drugs,

wherein the desired dosage amount of said one or more predetermined drugs is selected based on particular dosage requirements of said recipient and wherein said film is adhered to said medical device immediately prior to implantation of said medical device into said recipient.

19. An implantable drug-delivering medical device for implantation into a recipient, said device comprising:

an implantable medical device,

a film adhered to said device, said film comprising sodium alginate cross linked with calcium chloride, said film further comprising a desired dosage amount of one or more predetermined drugs,

wherein the desired dosage amount of said one or more predetermined drugs is selected based on particular dosage requirements of said recipient and wherein said film is adhered to said medical device immediately prior to implantation of said medical device into said recipient.